Caplight Directory>Companies>BIOCOM-preview>Biocom-kr


BIOCOM

BIOCOM

Private
SeoulHealthcare & Life Scienceshttps://biocom.kr

Last Round

Series A

Dec 29, 2025

Total Funding Raised

$2.17M

Company Overview

BIOCOM is a healthtech company that provides AI-powered personalized optimal health management solutions based on metabolome data analysis.

Sector

Healthcare & Life Sciences

Verticals

Precision Medicine, Medical AI, Telemedicine, Subscription Commerce, D2C Brands

Business Model

B2C

Customer Profile

Hardware Sales, Subscription SaaS

AI Layer

Application

Keywords

at-home health testspersonalized supplementsmetabolome analysisdirect-to-consumer healthcareDTC testingpersonalized health managementAI healthcaretelehealthgut microbiome testingbiohackingsubscription supplementsquantified selffood intolerance testingmulti-omics dataAI health coaching

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

BIOCOM Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

BIOCOM Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series ADec 29, 2025
Pre SeedNov 28, 2024
SeedDec 1, 2023
SeedOct 17, 2022
View all Funding Rounds

Key People

Founding team and executive leadership

Suhyun Yun

COO

Executive Team

BIOCOM Investors

Notable investors and investment history

InvestorRounds
NICE Investment PartnersSeries A
Shinhan Venture InvestmentSeries A
NH Nonghyup BankSeries A
View all Investors

BIOCOM Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

BIOCOM Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about BIOCOM's valuation, stock price, and market status.

Firmographic Details

HeadquartersSeoul
Employee Range3
Year Founded2022
Last FundingDec 29, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.